NEW ZEALAND GAZETTE, No. 89

9 AUGUST 2007

day-night pack containing dexchlorpheniramine or when
at least one of the other therapeutically active substances
is a sympathomimetic decongestant

Diclofenac; in solid dose form in medicines containing
12.5 milligrams or less per dose form in packs
containing not more than 20 tablets or capsules and
with a recommended daily dose of not more than
75 milligrams

Dimenhydrinate; for oral use in a sealed container of not
more than 10 tablets or capsules for the prevention or
treatment of motion sickness in adults and children over
two years of age except when sold at a transport terminal
or aboard a ship or plane

Diphenhydramine; for oral use in medicines for adults and
children over two years of age when combined in the
same container with one or more other therapeutically
active substances either when in the bedtime dose of a
day-night pack containing diphenhydramine or when at
least one of the other therapeutically active substances is
a sympathomimetic decongestant; for oral use in a sealed
container of not more than 10 tablets or capsules
of diphenhydramine theoclate for the prevention or
treatment of motion sickness in adults and children over
two years of age except when sold at a transport terminal
or aboard a ship or plane

Diphenylpyraline; for oral use in medicines for adults
and children over two years of age when combined in the
same container with one or more other therapeutically
active substances either when in the bedtime dose of a
day-night pack containing diphenylpyraline or when at
least one of the other therapeutically active substances is
a sympathomimetic decongestant

Doxylamine; for oral use in medicines for adults and
children over two years of age when combined in the
same container with one or more other therapeutically
active substances either when in the bedtime dose of a
day-night pack containing doxylamine or when at least
one of the other therapeutically active substances is a
sympathomimetic decongestant

*Fluticasone; for the treatment or prophylaxis of allergic
rhinitis in adults and children over 12 years of age when
in aqueous nasal sprays delivering up to 50 micrograms
per actuation and when the maximum recommended
daily dose is no greater than 200 micrograms and the
medicine has received the consent of the Minister or
the Director-General to its distribution as a pharmacy-only medicine

Hydrocortisone and hydrocortisone acetate but no other
esters of hydrocortisone; for dermal use in medicines
containing 0.5% or less by weight of hydrocortisone
base with no other ingredient except an antifungal and in
a quantity of 30 grams or less or 30 millilitres or less per
container; in rectal medicines containing 0.5% or less by
weight of hydrocortisone base and in combination with a
local anaesthetic and in a quantity of 35 grams or less
per container or 12 suppositories or less per pack

*Ibuprofen; for oral use in liquid form in packs containing
not more than 4 grams in medicines which have received
the consent of the Minister or the Director-General to
their sale as pharmacy-only medicines and which are
sold in the manufacturer’s original pack; for oral use in
solid dose form containing not more than 200 milligrams
per dose form and with a recommended daily dose of not
more than 1200 milligrams and in packs containing
not more than 100 tablets or capsules and when in
medicines which have received the consent of the
Minister or the Director-General to their sale as
pharmacy-only medicines and which are sold in the
manufacturer’s original pack; except in packs containing
200 milligrams or less per oral solid dose form and not

more than 25 dose units per pack when in medicines
which have received the consent of the Minister or the
Director-General to their sale as general sale medicines
and which are sold in the manufacturer’s original pack

Lithium; for dermal use in medicines containing 1%
or less but more than 0.01%; except when present as an
excipient in dermal medicines containing 0.25% or less

Lobeline; except when in medicines for smoking or burning

Mepyramine; for dermal use

*Mometasone; for the treatment or prophylaxis of allergic
rhinitis in adults and children over 12 years of age when
in aqueous nasal sprays delivering up to 50 micrograms
per actuation and when the maximum recommended
daily dose is no greater than 200 micrograms and the
medicine has received the consent of the Minister or
the Director-General to its distribution as a pharmacy-only medicine

Oxiconazole; for dermal use except in medicines for tinea
pedis only

Paracetamol; in liquid form; in suppositories; in tablets or
capsules containing 500 milligrams or less and in
packs containing more than 10 grams; in slow release
forms containing 665 milligrams or less and more than
500 milligrams; in powder form containing not more
than 1000 milligrams per sachet and more than 10 grams
per pack

Promethazine; for oral use in medicines for adults and
children over two years of age when combined in the
same container with one or more other therapeutically
active substances either when in the bedtime dose of a
day-night pack containing promethazine or when at least
one of the other therapeutically active substances is a
sympathomimetic decongestant; for oral use in a sealed
container of not more than 10 tablets or capsules for the
prevention or treatment of motion sickness in adults
and children over two years of age except when sold at a
transport terminal or aboard a ship or plane

*Triamcinolone; for the treatment or prophylaxis of allergic
rhinitis in adults and children over 12 years of age when
in aqueous nasal sprays delivering up to 55 micrograms
per actuation and when the maximum recommended
daily dose is no greater than 220 micrograms and
the medicine has received the consent of the Minister
or the Director-General to its distribution as a pharmacy-only medicine

Trimeprazine; for oral use in medicines for adults and
children over two years of age when combined in the
same container with one or more other therapeutically
active substances either when in the bedtime dose of a
day-night pack containing trimeprazine or when at least
one of the other therapeutically active substances is a
sympathomimetic decongestant

Triprolidine; for oral use in medicines for adults and
children over two years of age when combined in the
same container with one or more other therapeutically
active substances either when in the bedtime dose of a
day-night pack containing triprolidine or when at least
one of the other therapeutically active substances is a
sympathomimetic decongestant

Medicines for General Sale

Please note that the following medicines are no longer
classified as prescription medicines, restricted medicines or
pharmacy-only medicines. As such, they are now available
for general sale.

Choline salicylate; in medicines containing 10% or less and
in pack sizes of 15 grams or less

Etidronic acid; in medicines for external use containing
1% or less